Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor

Nature Chemical Biology

Volumn 8, Issue 2, 2012, Pages 141-143

  Koeberle, Solveigh C ^a,b   Romir, Johannes ^a   Fischer, Stefan ^a   Koeberle, Andreas ^c   Schattel, Verena ^a   Albrecht, Wolfgang ^d   Grütter, Christian ^e   Werz, Oliver ^c   Rauh, Daniel ^e   Stehle, Thilo ^a,f   Laufer, Stefan A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d C a i r Biosciences GmbH   (Germany)

^e TU DORTMUND UNIVERSITY   (Germany)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; DORAMAPIMOD; GAMMA INTERFERON; HEAT SHOCK PROTEIN 27; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SKEPINONE L; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL SELECTION; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; HELA CELL; HUMAN; HYDROPHILICITY; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 84856083088     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.761     Document Type: Article

References (25)

1. Wagner, E.F. & Nebreda, A.R. Nat. Rev. Cancer 9, 537-549 (2009).
2. Veillat, V. et al. J. Clin. Endocrinol. Metab. 95, E403-E412 (2010).
3. Xie, N. et al. Neuropharmacology 59, 444-451 (2010).
4. Goldstein, D.M. & Gabriel, T. Curr. Top. Med. Chem. 5, 1017-1029 (2005).
5. Karaman, M.W. et al. Nat. Biotechnol. 26, 127-132 (2008).
6. Lee, M.R. & Dominguez, C. Curr. Med. Chem. 12, 2979-2994 (2005).
7. Karcher, S.C. & Laufer, S.A. Curr. Top. Med. Chem. 9, 655-676 (2009).
8. Fitzgerald, C.E. et al. Nat. Struct. Biol. 10, 764-769 (2003).
9. Laufer, S.A., Ahrens, G.M., Karcher, S.C., Hering, J.S. & Niess, R. J. Med. Chem. 49, 7912-7915 (2006).
10. Karcher, S.C. & Laufer, S.A. J. Med. Chem. 52, 1778-1782 (2009).
11. Goldstein, D.M. et al. J. Med. Chem. 49, 1562-1575 (2006).
12. Dinarello, C.A. Semin. Dial. 22, 256-259 (2009).
13. Mutou, Y., Tsukimoto, M., Homma, T. & Kojima, S. J. Health Sci. 56, 675-683 (2010).
14. Schett, G., Zwerina, J. & Firestein, G. Ann. Rheum. Dis. 67, 909-916 (2008).
15. Ip, W.K., Wong, C.K. & Lam, C.W. Clin. Exp. Immunol. 145, 162-172 (2006).
16. Pan, S.L. et al. Shock 30, 496-502 (2008).
17. Peng, H. et al. J. Biol. Chem. 286, 24508-24518 (2011).
18. Schieven, G.L. Curr. Top. Med. Chem. 9, 1038-1048 (2009).
19. Shimada, H. & Rajagopalan, L.E. J. Biol. Chem. 285, 12536-12542 (2010).
20. Ip, W.K., Wong, C.K., Wang, C.B., Tian, Y.P. & Lam, C.W. Immunopharmacol. Immunotoxicol. 27, 371-393 (2005).
21. Tibbles, L.A. et al. J. Virol. 76, 1559-1568 (2002).
22. Cekic, C. et al. J. Biol. Chem. 284, 31982-31991 (2009).
23. Hill, R.J. et al. J. Pharmacol. Exp. Ther. 327, 610-619 (2008).
24. Kurihara, Y., Nakahara, T. & Furue, M. Cell. Immunol. 270, 25-31 (2011).
25. Manning, G., Whyte, D.B., Martinez, R., Hunter, T. & Sudarsanam, S. Science 6, 1912-1934 (2002).